Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 5 | 2022 | 261 | 0.990 |
Why?
|
| Patient Compliance | 1 | 2017 | 473 | 0.430 |
Why?
|
| Radiation Pneumonitis | 1 | 2012 | 10 | 0.390 |
Why?
|
| Protons | 1 | 2012 | 98 | 0.380 |
Why?
|
| Esophageal Neoplasms | 2 | 2012 | 387 | 0.350 |
Why?
|
| Brachytherapy | 3 | 2020 | 95 | 0.330 |
Why?
|
| Chemoradiotherapy | 4 | 2022 | 124 | 0.300 |
Why?
|
| Radiosurgery | 2 | 2020 | 147 | 0.270 |
Why?
|
| Pain, Procedural | 1 | 2020 | 8 | 0.170 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 38 | 0.160 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2020 | 39 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 60 | 0.160 |
Why?
|
| Analgesics | 1 | 2020 | 127 | 0.150 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 46 | 0.140 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 56 | 0.130 |
Why?
|
| Pneumonectomy | 1 | 2017 | 148 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 959 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1132 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 767 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1305 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 333 | 0.100 |
Why?
|
| Middle Aged | 7 | 2022 | 28998 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2012 | 68 | 0.100 |
Why?
|
| Quality of Life | 1 | 2022 | 2161 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2020 | 17416 | 0.090 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 134 | 0.090 |
Why?
|
| Multimodal Imaging | 1 | 2012 | 110 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 207 | 0.090 |
Why?
|
| Proton Therapy | 1 | 2012 | 159 | 0.080 |
Why?
|
| Age Factors | 1 | 2017 | 2916 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 308 | 0.080 |
Why?
|
| Metformin | 1 | 2012 | 166 | 0.080 |
Why?
|
| Female | 9 | 2022 | 70695 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 482 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1538 | 0.070 |
Why?
|
| Aged | 5 | 2020 | 21438 | 0.060 |
Why?
|
| Neoplasm Staging | 2 | 2022 | 1362 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1015 | 0.060 |
Why?
|
| Adult | 5 | 2022 | 31575 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2169 | 0.050 |
Why?
|
| Humans | 9 | 2022 | 132089 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 7104 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 923 | 0.050 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2022 | 11 | 0.050 |
Why?
|
| Cystoscopy | 1 | 2022 | 46 | 0.050 |
Why?
|
| Safety-net Providers | 1 | 2022 | 70 | 0.050 |
Why?
|
| Urban Population | 1 | 2022 | 245 | 0.040 |
Why?
|
| Promethazine | 1 | 2020 | 5 | 0.040 |
Why?
|
| Hydromorphone | 1 | 2020 | 12 | 0.040 |
Why?
|
| Lorazepam | 1 | 2020 | 12 | 0.040 |
Why?
|
| Antiemetics | 1 | 2020 | 23 | 0.040 |
Why?
|
| Organs at Risk | 1 | 2020 | 42 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 41 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 2020 | 77 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2020 | 237 | 0.040 |
Why?
|
| Rectum | 1 | 2020 | 114 | 0.040 |
Why?
|
| Radiography | 1 | 2022 | 819 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 367 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2020 | 254 | 0.040 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2018 | 22 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 282 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 99 | 0.040 |
Why?
|
| Veterans Health | 1 | 2017 | 175 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1722 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1573 | 0.030 |
Why?
|
| Male | 3 | 2017 | 64967 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1183 | 0.020 |
Why?
|
| Esophagectomy | 1 | 2012 | 68 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6572 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 713 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1826 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3831 | 0.020 |
Why?
|
| Lung | 1 | 2017 | 1559 | 0.020 |
Why?
|
| United States | 1 | 2017 | 11667 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 9958 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 13034 | 0.010 |
Why?
|